Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1B | P47901 | 7/20 | 0.54 |
| ▸ | AVPR1A | P37288 | 7/20 | 0.47 |
| ▸ | PLG | P00747 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
| ▸ | BMP1 | P13497 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1509781 | 1.00 | AVPR1B (0.54) | AVPR1BAVPR1APLGITGB3ITGA2B | |
| SCHEMBL1509780 | 1.00 | AVPR1B (0.54) | AVPR1BAVPR1APLGITGB3ITGA2B | |
| SCHEMBL7898282 | 1.00 | AVPR1B (0.54) | AVPR1BAVPR1APLGITGB3ITGA2B | |
| SCHEMBL9329697 | 0.93 | AVPR1B (0.52) | AVPR1BAVPR1APLGBMP1F2 | |
| Phenylalanine SCHEMBL6286710 | 0.90 | AVPR1B (0.59) | AVPR1BAVPR1APLGBMP1F2 | |
| SCHEMBL2873083 | 0.88 | AVPR1B (0.48) | AVPR1BAVPR1APLGBMP1F2 | |
| SCHEMBL1738663 | 0.88 | AVPR1B (0.52) | AVPR1BAVPR1APLGBMP1 | |
| SCHEMBL29816989 | 0.88 | AVPR1B (0.48) | AVPR1BAVPR1APLGBMP1F2 | |
| SCHEMBL3501647 | 0.87 | AVPR1B (0.47) | AVPR1BAVPR1APLGBMP1F2 | |
| SCHEMBL7368157 | 0.87 | AVPR1B (0.47) | AVPR1BAVPR1APLGBMP1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121577501-A | Polypeptide aggregation trend prediction method based on dynamic light scattering | 中肽生化有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-11471868-B2 | Redox dehydration coupling catalysts and methods related thereto | EMORY UNIVERSITY (US) | 2022-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11471868-B2 | Redox dehydration coupling catalysts and methods related thereto | SCLY, TST, SQOR | AVPR1B 3743/4885AVPR1A 3549/4885PLG 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.